NEWS

Keep up with the latest news and updates at Alveo

Development and Laboratory Validation of Rapid, Bird-Side Molecular Diagnostic Assays for Avian Influenza Virus Including Panzootic H5Nx
Development and Laboratory Validation of Rapid, Bird-Side Molecular Diagnostic Assays for Avian Influenza Virus Including Panzootic H5Nx
eclipse image
News

Avian influenza A viruses (AIV) significantly impact both animal and human health.

Avian influenza A viruses (AIV) significantly impact both animal and human health.

Go to Story
Go to Story
chevron down icon
By Investing in Solutions, Government and Industry are Leading the Way to Help Curb the Avian Flu Catastrophe
By Investing in Solutions, Government and Industry are Leading the Way to Help Curb the Avian Flu Catastrophe
eclipse image
Blog

In my first LinkedIn article in January, I addressed the growing threat of HPAI...

In my first LinkedIn article in January, I addressed the growing threat of HPAI...

Go to Story
Go to Story
chevron down icon
Alveo Technologies Appoints Nobel Laureate, Dr. James Rothman, to its Board of Directors
Alveo Technologies Appoints Nobel Laureate, Dr. James Rothman, to its Board of Directors
eclipse image
Press Release

Dr. Rothman is a distinguished biochemist and cell biologist whose work led to understand

Dr. Rothman is a distinguished biochemist and cell biologist whose work led to understand

Go to Story
Go to Story
chevron down icon
Alveo Technologies and Royal GD Form Long-Term Partnership to Expand Joint Offerings for Rapid, Molecular Animal Diagnostics at Point of Need
Alveo Technologies and Royal GD Form Long-Term Partnership to Expand Joint Offerings for Rapid, Molecular Animal Diagnostics at Point of Need
eclipse image
Press Release

Their first co-developed product, an Avian Influenza test was introduced in 2024

Their first co-developed product, an Avian Influenza test was introduced in 2024

Go to Story
Go to Story
chevron down icon
Alveo Partnerships are Driving Innovation and Impact
Alveo Partnerships are Driving Innovation and Impact
eclipse image
Blog

Alveo Partnerships are Driving Innovation and Impact.

Alveo Partnerships are Driving Innovation and Impact.

Go to Story
Go to Story
chevron down icon
CA's emergency bird flu declaration and the US's first death from it begs the question: Why aren't we doing more as a nation to curb this catastrophe?
CA's emergency bird flu declaration and the US's first death from it begs the question: Why aren't we doing more as a nation to curb this catastrophe?
eclipse image
Blog

We as a nation have an opportunity to curb the continued spread of HPAI

We as a nation have an opportunity to curb the continued spread of HPAI

Go to Story
Go to Story
chevron down icon
2024 in Review: Key Milestones in Point of Need Molecular Diagnostics and What’s Next for Alveo
2024 in Review: Key Milestones in Point of Need Molecular Diagnostics and What’s Next for Alveo
eclipse image
Blog

Setting the stage for a paradigm shift in molecular diagnostics...

Setting the stage for a paradigm shift in molecular diagnostics...

Go to Story
Go to Story
chevron down icon
Alveo Technologies and Fraunhofer Partner to Develop First-of-its-Kind Rapid, Molecular Feline Respiratory Panel Diagnostic
Alveo Technologies and Fraunhofer Partner to Develop First-of-its-Kind Rapid, Molecular Feline Respiratory Panel Diagnostic
eclipse image
Press Release

The two companies will develop a test for feline influenza, calicivirus and herpes viru...

The two companies will develop a test for feline influenza, calicivirus and herpes viru...

Go to Story
Go to Story
chevron down icon
Alveo Technologies Enters Agreement with CDC to Develop a Point of Need Spatial Multiplexed Test for Avian Influenza A(H5) Virus in Humans
Alveo Technologies Enters Agreement with CDC to Develop a Point of Need Spatial Multiplexed Test for Avian Influenza A(H5) Virus in Humans
eclipse image
Press Release

The agreement seeks to leverage Alveo's point of need molecular testing platform for early

The agreement seeks to leverage Alveo's point of need molecular testing platform for early

Go to Story
Go to Story
chevron down icon

Media Inquiries

If you're a member of the media and would like to talk, please send an email to: Alveo1@spectrumscience.com